Product Safety Recalls and Alerts

Brand/Company
Product
Reason
Lot Code
Date
Additional Information
HospiraPropofol Injectable Emulsion, 1%, 200 mg / 20 mL (10 mg/mL)glass defect and free-floating metal particulates Lot numbers 29-614-DJ, 29-615-DJ, 29-616-DJ, 29-617-DJ, 29-628-DJ, 29-629-DJ, 29-630-DJ; all with expiration date of 1MAY20154/17/2014 More Information
Agila Specialties Private LimitedEtomidate Injection 2 mg/mL – 10 mL Presence of particulate matter and/or illegible and missing lot number and/or expiry dateAll of the products bear a Pfizer label. 5001023, exp Sep-14; 5000983, exp Aug-14; 5000986, exp Aug-142/19/2014 More Information
Agila Specialties Private LimitedEtomidate Injection 2 mg/mL – 20 mLPresence of particulate matter and/or illegible and missing lot number and/or expiry dateAll of the products bear a Pfizer label. 5001012, exp Sep-14; 5000927, exp Jun-14; 5000931, exp Jun-14; 5000936 exp Jun-14; 5000942 exp Jun-14; 5001071, exp Oct-14; 5001040, exp Sep-142/19/2014 More Information
Roxane LaboratoriesAcetylcysteine Solution 10%Glass particlesLot 2005479 – Exp. Date March 2014.2/15/2014 More Information
Rx FormulationsCalcium gluconate 10% injectionsPossible microbial contaminationlot #7789612/7/2014 More Information
Hospira, Inc.1% Lidocaine HCI Injection, USP, 10 mg/mL, 20 mL Multiple-dose Fliptop Vial, NDC 0409-4276-01particulate floating and/or embedded in the glass vialLot 25-090-DK (the lot number may be followed by 01 or 02)10/4/2013 More Information
Hospira, Inc.Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL)particulate floating and/or embedded in the glass vialLot 28-104-DK (the lot number may be followed by a 01), is packaged in a 2 mL single-dose fliptop vial, with an expiration date of October 1, 201410/2/2013 More Information
Hospira, Inc.Ondansetron Injection, USP, 4 mg/2 mL, (2 mg/mL)particulate floating and/or embedded in the glass vialLots 29-484-DK and 29-510-DK (the lot numbers may be followed by a 01) are packaged in a 2 mL single-dose fliptop vial, with an expiration date of May 1, 201510/2/2013 More Information
Hospira, Inc. 0.25% Bupivacaine HCl Injection, USP (2.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1159-02)particulate floating and/or embedded in the glass vialLot 18-136-DK was distributed August 2012 through September 2012. Lot 23-338-DK was distributed January 2013 through May 20139/13/2013 More Information
Hospira, Inc.0.75 Bupivacaine HCl Injection, USP (7.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1165-02)particulate floating and/or embedded in the glass vialLot 18-136-DK was distributed August 2012 through September 2012. Lot 23-338-DK was distributed January 2013 through May 20138/29/2013 More Information
VirbacIverhart Plus Flavored Chewables for small dogs (up to 25 lbs)below Ivermectin potency levels prior to their expiration120092, 120397, 120398, 1207988/22/2013 More Information
VirbacIverhart Plus Flavored Chewables for medium dogs (26-50 lbs)below Ivermectin potency levels prior to their expiration120090, 120301, 120378, 120450, 1212828/22/2013 More Information
VirbacIverhart Plus Flavored Chewables for large dogs (51-100 lbs)below Ivermectin potency levels prior to their expiration120091, 120127, 120195, 120207, 120256, 120289, 120300, 120305, 120306, 120377, 120379, 120434, 120440, 120464, 120651, 120658, 120678, 120831, 121110, 121150, 121283, 121386 8/22/2013 More Information
SandozMethotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectableparticulate matter in vialsCL0996 (expiration date 12/2013) and CJ4948 (expiration date 05/2013)5/20/2013 More Information
Banfield Worm Shield for dogs, small (up to 25 lbs) concerns that it may not fully protect pets through the expiration date120844, 1201965/14/2013 More Information
BanfieldWorm Shield for dogs, medium (26-50 lbs)concerns that it may not fully protect pets through the expiration date120845; 1202025/14/2013 More Information
VirbacIverhart Plus Flavored Chewables, large size (51-100 lbs)failure to meet stability specifications during the life of the productLot 120076 ; Lot 120086 ; Lot 120856 4/10/2013 More Information
VirbacIverhart Plus Flavored Chewables, medium size (26-50 lbs)failure to meet stability specifications during the life of the productLot 120202 4/10/2013 More Information
VirbacIverhart Plus Flavored Chewables, small size (up to 25 lbs)failure to meet stability specifications during the life of the productLot 120196; Lot 1208444/10/2013 More Information
Hospira0.9% Sodium Chloride Injection, USP, 1000 mL, Flexible Container, NDC 0409-7983-09brass particulate25-037-JT (the lot number may be followed by a -01 or -90), with an expiration date of January 1, 20154/1/2013 More Information
HospiraLactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible ContainerNon-Sterilitylot number 05-019-JT, with an expiration date of May 1, 20131/28/2013 More Information
HospiraCarboplatin injectionVisible particulate matter12/14/2012 More Information
LloydThyro Tabs 0.3mg in 1000ct incorrect in-process specification for blend uniformity criteriaKB157118/28/2012 More Information
LloydThyro Tab 0.3mg in 120ctincorrect in-process specification for blend uniformity criteriaKB157118/28/2012 More Information
LloydThyro Tab 1.0mg in 1000ctincorrect in-process specification for blend uniformity criteriaKB173118/28/2012 More Information
LloydThyro Tab 1.0mg in 120ctincorrect in-process specification for blend uniformity criteriaKB173118/28/2012 More Information
LloydThyro Tab 0.7mg in 1000ctincorrect in-process specification for blend uniformity criteriaKB180118/28/2012 More Information
LloydThyro Tab 0.7mg in 120ctincorrect in-process specification for blend uniformity criteriaKB180118/28/2012 More Information
LloydThyro Tab 0.2mg in 1000ctincorrect in-process specification for blend uniformity criteriaKA166118/28/2012 More Information
LloydThyro Tab 0.2mg in 120ctincorrect in-process specification for blend uniformity criteriaKA166118/28/2012 More Information
VedcoThyrosyn Tab 0.8mg in 1000ctincorrect in-process specification for blend uniformity criteriaKD11711, KD11711A8/28/2012 More Information
VedcoThyrosyn Tab 0.3mg in 1000ctincorrect in-process specification for blend uniformity criteriaKB13611, KB13611A8/28/2012 More Information
VedcoThyrosyn Tab 0.3mg in 180ctincorrect in-process specification for blend uniformity criteriaKB13611, KB13611A8/28/2012 More Information
VedcoThyrosyn Tab 0.7mg in 180ctincorrect in-process specification for blend uniformity criteriaKB18011, KB18011A8/28/2012 More Information
ClipperThyrozine Tab 0.3mg in 1000ctincorrect in-process specification for blend uniformity criteriaKB13611, KB13611a, KB157118/28/2012 More Information
ClipperThyrozine Tab 0.3mg in 180ctincorrect in-process specification for blend uniformity criteriaKB15711F8/28/2012 More Information
ClipperThyrozine Tab 0.7mg in 1000ctincorrect in-process specification for blend uniformity criteriaKB180118/28/2012 More Information
ClipperThyrozine Tab 0.7mg in 180ctincorrect in-process specification for blend uniformity criteriaKB18011F, KB18011FA8/28/2012 More Information
SynthesHemostatic Bone PuttyPotential to ignite if contacted with electrosurgical cautery systems under certain conditions during surgery.8/21/2012 More Information
HospiraHydromorphone Injection, USP, 2 mg/mL, (C-II), 1 mL fill in 2.5 mL Carpujectreported complaint of a single Carpuject containing more than the 1 mL labeled fill volume12720LL, exp Dec 1, 20138/16/2012 More Information
HospiraPropofol Injectable Emulsion, 1%, 1 g / 100 mL (10 mg/mL)visible particles embedded in the glass07-893-DJ (exp 01JUL2013);  10-123-DJ (exp 01OCT2013);  10-125-DJ (exp 01OCT2013) 8/14/2012 More Information
SmithsMedical Medfusion Model 4000 Syringe Infusion Pump with software Versions V1.0 and V1.1system errors that can cause the pump to go into an alarm condition and stop running, resulting in a delay or an interruption of patient therapyAffected pumps were distributed from September 10, 2010, to February 3, 20128/3/2012 More Information
Dukal CorporationZee Antiseptic Swabs, Med 2ply, 50/box, 36box/casepotential microbial contamination with Burkholderia cepaciaJT14509; JT15209; JT20609; JT20909; JT23709; JT27809; JT32809; JT00710; JT15810; JT18310; JT18810; JT23210; JT25810; JT27610; JT31510; JT35610; JT35911; JT04811; JT05311; JT11811; JT15211; JT15911; JT18211; JT21511-1; JT26311; JT30711; JT22011-1; JT01012; JT04112l; JT06512; JT075127/25/2012 More Information
Dukal CorporationZee Antiseptic Swab, Med 2 ply, 100/bx, 20bx/cspotential microbial contamination with Burkholderia cepaciaJT14509; JT15209; JT21409; JT20609; JT22009; JT00710; JT18810; JT23210; JT35911; JT05311; JT11811; JT26311; JT010127/25/2012 More Information
Dukal CorporationDukal BZK Swab Med. 2 ply NS, 1/pch200/bx20bx/cspotential microbial contamination with Burkholderia cepaciaJT00610; JT14511; JT22011; JT307117/25/2012 More Information
Dukal CorporationZee Antiseptic Swab, Med 2 ply, 50/box 36bx/cspotential microbial contamination with Burkholderia cepaciaJT14509; JT15209; JT20609; JT15209; JT23709; JT27809; JT00710; JT18310; JT18810; JT23210’ JT27610; JT315107/25/2012 More Information
Dukal CorporationZee Antiseptic Swab, Med, 2ply, 10/bx,10bx/bdl,6bdl/cspotential microbial contamination with Burkholderia cepaciaJT14509; JT15209; JT21209; JT27809; JT12510; JT15810; JT18310; JT11811; JT13211; JT15911; JT35911; JT01012; JT307117/25/2012 More Information
Dukal CorporationDukal BZK Swab Med. 2 ply NS, 1/pch1000/bx4bx/cspotential microbial contamination with Burkholderia cepaciaJT34808; JT08209; JT15209; JT32809; JT00610; JT27610; JT05311; JT08011; JT18211; JT22711-1; JT26411; JT01012; JT01411; JT14611; JT29011; JT012127/25/2012 More Information
HospiraCarboplatin Injection, 450 mg/ 45 mL, 10 mg/mL, Cytotoxic Agent, 45 mL Multi Dose Vialvisible particles embedded in the glass located at the neck of the vialList no. 003390450; Batch nos. Y061711AA and Y061711AB; exp dates February 20137/13/2012 More Information
HospiraCytarabine Injection, 1000 mg/ 50 mL, 20 mg/mL, Cytotoxic Agent, 50 mL Vialvisible particles embedded in the glass located at the neck of the vialList no. 003030446; Batch nos. Y131994AA (exp. August 2013), Y141994AA (exp September 2013), Y151994AA (exp September 2013), Y161994AA (exp November 2013), Y171994AA (exp November 2013), Y181994AA (exp November 2013)7/13/2012 More Information
HospiraPaclitaxel Injection, 300 mg/ 50 mL, 6 mg/mL, Cytotoxic Agent, 50 mL Multiple Dose Vialvisible particles embedded in the glass located at the neck of the vialList no. 003420450; Batch nos. Y096865AA (exp August 2013); Y106865AA (exp August 2013); Y116865AA (exp August 2013); Y126865AA (exp September 2013); Y136865AA (exp September 2013); Y146865AA (exp September 2013); Y156865AA (exp October 2013); Y166865AA (exp November 2013); Y176865AA (exp November 2013); Y186865AA (December 2013) 7/13/2012 More Information
HospiraMethotrexate Injection, USP, 1 g/ 40 mL, 25 mg/mL, Cytotoxic Agent, 40 mL Vialvisible particles embedded in the glass located at the neck of the vialList no. 004080441; Batch no. Y064457AA; exp October 20137/13/2012 More Information
Petcostainless steel bowls 9.25” in diameter, 3.75 cup capacitycontaminated with low-levels of cobalt-60, a radioactive materialSKU number 10474936/29/2012 More Information
American RegentEpinephrine Injection, USP, 1:1000, 1 mL Ampules NDC #0517-1071-25discoloration and small visible particlesLot #1395, Exp Date: July 20124/24/2012 More Information
American RegentEpinephrine Injection, USP, 1:1000, 1 mL Ampules NDC #0517-1071-25Discoloration and small visible particlesLot #1395, Exp Date: July 20124/24/2012 More Information
VirbacIverhart Max chewable tablets for dogs 50.1-100 lbsivermectin failed to meet the company's stability specificationsLot # 1104824/13/2012 More Information
American RegentCyanocobalamin Injection, USP, 1000 mcg/mL, 1mL Vial, NDC # 0517-0031-25Cracks in vialsLot # 1662, Exp Date: November, 2013Lot # 1679, Exp Date: November, 2013Lot # 1683, Exp Date: November, 20134/2/2012 More Information
American RegentPhenylephrine HCl Injection, USP, 1% 5 mL Vialvisible particlesLot # 06932/23/2012 More Information
Bedford LaboratoriesCytarabine for Injection, USP, 1 gm per vial (NDC #55390-133-01)potential elevated risk of a lack of sterility assuranceLot 2066986 - Exp. Date March 31, 2014; Lot 2111675 - Exp. Date April, 30, 2014; Lot 2131148 - Exp. Date May, 31, 20142/16/2012 More Information
Novartis Animal HealthClomicalm 5 mgPossibility that a wrong tablet might be found in some 30-count bottleslot number 100987761/25/2012 More Information
Novartis Animal HealthClomicalm 20 mgPossibility that a wrong tablet might be found in some 30-count bottleslot numbers 10122354, 10098779, 10085841, 10079205, 10072783, 100639731/25/2012 More Information
Novartis Animal HealthClomicalm 40 mgPossibility that a wrong tablet might be found in some 30-count bottleslot numbers 10120764, 10098775, 10092743, 10082033, 10072784, 100618941/25/2012 More Information
Novartis Animal HealthClomicalm 80 mgPossibility that a wrong tablet might be found in some 30-count bottleslot numbers 10125584, 10115214, 10098781, 10092746, 10082034, 10072785, 100651831/25/2012 More Information